163928-96-9 Usage
Uses
Used in Pharmaceutical Industry:
<1S-(1α,2β,3α)>-3-(2-Amino-6-iodo-7H-purin-7-yl)-1,2-cyclobutanedimethanol dibenzoate ester is used as a potential pharmaceutical agent for [application reason] due to its purine derivative backbone, which is known for its biological activity and pharmacological significance.
(Note: The specific application reason is not provided in the materials, so it is left blank. Further research would be needed to identify the exact use within the pharmaceutical industry.)
Used in Research and Development:
<1S-(1α,2β,3α)>-3-(2-Amino-6-iodo-7H-purin-7-yl)-1,2-cyclobutanedimethanol dibenzoate ester is used as a research compound for studying its potential biological activities and pharmacological effects, as well as for the development of new drugs and therapies based on its structure and properties.
(Note: The specific application type and reason are not provided in the materials, so a general application in research and development is suggested based on the compound's potential pharmaceutical properties.)
Check Digit Verification of cas no
The CAS Registry Mumber 163928-96-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,9,2 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 163928-96:
(8*1)+(7*6)+(6*3)+(5*9)+(4*2)+(3*8)+(2*9)+(1*6)=169
169 % 10 = 9
So 163928-96-9 is a valid CAS Registry Number.
163928-96-9Relevant academic research and scientific papers
A practical asymmetric synthesis of the antiviral agent lobucavir, BMS-180194
Singh, Janak,Bisacchi, Gregory S.,Ahmad, Saleem,Godfrey Jr., Jollie D.,Kissick, Thomas P.,Mitt, Toomas,Kocy, Octavian,Vu, Truc,Papaioannou, Chris G.,Wong, Michael K.,Heikes, James E.,Zahler, Robert,Mueller, Richard H.
, p. 393 - 399 (2013/09/08)
A practical synthesis of the antiviral agent lobucavir, [1R-(1α,2β,3α)]-2-amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]- 6H-purin-6-one (BMS-180194), is described. The key chiral intermediate, [1S-(1α,2β,3α)]-3-hydroxy-1,2-cyclobutanedimethanol, dibenzoate e